Treatment approach
An integrated approach to
treating cancer
My goal is to integrate metabolic strategies with conventional oncology care, creating a comprehensive and individualized treatment plan.
Core treatment principles
01
Targeting cancer metabolism
Ketogenic nutritional strategies
Fasting protocols when appropriate
Supporting metabolic flexibility
02
Repurposed medications
Some medications approved for other conditions are being investigated for effects on cancer-cell metabolism, microtubules and cell death. Promising laboratory or animal results do not establish improved survival or cancer control in patients.
Ivermectin and mebendazole have human uses but are not approved cancer treatments. Fenbendazole is a veterinary drug and is not approved for human use; it should not be treated as an equivalent off-label human medication.
Potential risks include liver injury and interactions with cancer treatments or other medications. Any consideration requires a review of the evidence, informed discussion and appropriate monitoring.
03
Oxidative & metabolic therapies
Hyperbaric oxygen therapy
High-dose IV vitamin C
Other oxidative strategies
04
Immune & lifestyle support
Optimizing vitamin D
Regular physical activity
Nutritional support
Stress reduction & sleep
Integration with conventional oncology
I frequently work with patients undergoing chemotherapy, radiation, immunotherapy or surgery. I evaluate integrative strategies for their potential to support nutrition, well-being and treatment tolerance, while reviewing evidence and possible interactions. Benefits vary by strategy and patient. The goal is not to replace conventional care, but to support an individualized plan alongside your oncology team.
A focus of my practice
Metabolic oncology & Press–Pulse therapy
Boston College researcher Dr. Thomas Seyfried studies cancer as a mitochondrial metabolic disease. His work examines how altered energy production and reliance on fuels such as glucose and glutamine may create treatment opportunities. This research is an important influence on my approach to integrative oncology.
The Press–Pulse framework described by Seyfried and colleagues combines ongoing metabolic pressure with intermittent, targeted interventions. The proposed aim is to make tumor cells more vulnerable while limiting harm to healthy tissue. Many normal cells can use fatty acids and ketones, but fuel use varies among cancers; it is not accurate to assume every tumor lacks that flexibility.
The “Press” - sustained metabolic pressure
The “press” is a sustained change in the metabolic environment. Research explores nutritional strategies that reduce glucose availability and insulin signaling over time, with the aim of placing pressure on tumor metabolism rather than delivering a single treatment.
Individualized ketogenic nutritional strategies when appropriate
Attention to glucose regulation and metabolic health
Adequate protein, calories and ongoing nutritional assessment
Fasting or calorie restriction is not appropriate for everyone, especially patients losing weight or at risk of malnutrition. Nutrition plans require clinical supervision and adjustment.
The “Pulse” - intermittent interventions
The “pulse” refers to intermittent interventions intended to exploit vulnerabilities created by the press. Timing and combinations are central to the research model, rather than simply adding several therapies at once.
Investigational approaches targeting glutamine metabolism
Research into oxidative interventions, including hyperbaric oxygen
Careful evaluation of medication combinations and timing
Some interventions remain experimental or are available only in research settings. They are not a self-treatment protocol, and protecting healthy tissue is an aim not a guarantee.
From research to an individualized care plan
The framework helps guide the questions I ask about a patient's metabolism, nutrition and treatment options. I review diagnosis, stage, current therapies, weight, organ function and goals before considering any strategy, and reassess tolerance and progress over time with attention to coordination with the oncology team.
Much of the evidence for Press–Pulse comes from laboratory and animal studies, with limited clinical reports and ongoing investigation. The complete approach is not an established standard of cancer care, and improved survival across cancer types has not been demonstrated. A published mechanism or encouraging individual report is not the same as evidence from well-designed clinical trials.
Important note: Every patient is unique. Plans are individualized based on diagnosis, stage, current treatments and overall health.
Research & resources
Published scientific research
Peer-reviewed publications on metabolic therapy and supportive cancer care.
Educational videos & interviews
Patient resources
Ready to explore your options?
Book a one-hour telehealth consultation and receive an individualized plan.
Doc Scott MD
Compassionate integrative cancer care via telehealth.
Biography
Treatment
Prevention
Contact
Book appointment
Metabolic cancer
Breast care
Get healthy
Consultations
Note: Card charges appear as "Equipping Children and Families for Success Inc" - a non-profit Christian church, school and orphanage in Nairobi, Kenya.
Learn more at ProjectRestoreHope.com.
Thank you, and may God bless you.
© 2026 DocScottMD.com